Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
Makino
Shintaro
S
Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo, Japan. shintaro@med.Juntendo.ac.jp
Yonemoto
Hisashi
H
Itoh
Shigeru
S
Takeda
Satoru
S
D000974:Antibodies, Antinuclear / Q000097:blood / Q000276:immunology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006327:Heart Block / Q000151:congenital* / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications / Q000276:immunology; D010956:Plasmapheresis / Q000379:methods*; D011239:Prednisolone / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood* / Q000276:immunology; D012859:Sjogren's Syndrome / Q000097:blood / Q000150:complications / Q000276:immunology; D016896:Treatment Outcome
D000974:Antibodies, Antinuclear; D005938:Glucocorticoids; C035356:SS-A antibodies; C035357:SS-B antibodies; D011239:Prednisolone